![]() |
市場調查報告書
商品編碼
991638
BCG疫苗的全球市場:2020∼2027年Global BCG Vaccine Market, Size, Share, Opportunities and Forecast, 2020-2027 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
促進BCG疫苗市場成長的主要原因,尤其是開發中國家和低度開發國家的結核盛行率增加,及疫苗研究的領域的技術開發。還有全球,尤其是中國與印度的出生率上升,造成市場大幅度成長。加上,政府的政策提高及全球的疫苗接種計劃的重視,更加促進需求擴大。
BCG疫苗的副作用,預計是在預測期間抑制全球市場成長的重要要素。再加上新興國家的BCG疫苗的供不應求,不久的將來,預計是妨礙市場整體成長的另一個要素。
本報告提供全球BCG疫苗市場相關調查分析,市場概要,市場成長的影響要素,各市場區隔、各地區的市場規模和與前一年同期比較成長,及主要企業等相關分析。
Global BCG Vaccine Market Is Segmented By Product Segment By (Immune BCG, Therapy BCG), By Demographics Segment (Pediatrics (0-18 Years), Adults (19-35 Years), By Application Segment (Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027
The Global BCG Vaccine Market is expected to grow at a CAGR during the forecasting period (2020-2027).
The only vaccine available to combat Tuberculosis is the Bacillus Calmette-Gurin (BCG) vaccine (TB). One dose is recommended for healthy babies near the time of birth in countries with a high incidence of Tuberculosis. However, only infants at high risk are usually immunized in areas where Tuberculosis is rare, while confirmed cases of Tuberculosis are personally screened and administered. It is also possible to immunize individuals who are not afflicted with Tuberculosis and who have not been recently immunized yet are also susceptible to drug-resistant Tuberculosis.
Product: DataM Intelligence Analysis (2019)
The major factors propelling the growth of the BCG vaccine market are Increases in tuberculosis prevalence, especially in developing and underdeveloped countries, as well as technical developments in the field of vaccine research. Also, the rising birth rates across the globe, especially in China and India, contribute to the market's significant growth. Also, the rise in government policies and a global emphasis on immunization programs further drive demand growth. It is expected that untapped business opportunities in emerging regions can have multiple market growth prospects.
Increasing prevelance of Tuberculosis in developing and under-developed countries
The increasing prevalence of Tuberculosis across the globe, especially in developing and under-developed countries such as India, China, Africa, will stir the demand for BCG vaccine as it is the only vaccine available for the disease. As per the TB Alert organization, It is estimated that a fifth of the global population is afflicted with latent TB. Of these individuals, one in ten will begin to contract the disorder. And about 10 million individuals develop TB annually, contributing to 1.6 million deaths. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent ). This high prevalence in emerging countries drives the market for BCG vaccines during the forecast period.
Side effects of BCG vaccine
The side effects of BCG vaccine among individuals are a key factor expected to curtail the global market's growth over the forecast period. Moreover, the shortage of supply in BCG vaccine in emerging countries is another factor expected to hinder the total market's growth in the near future. As UNICEF administered a shortage of 16.7 million BCG vaccines due to less supply capacity.
COVID-19 Impact Analysis
The outbreak of COVID-19 has negatively impacted the growth of the BCG vaccine market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. The escalated focus on COVID-19 vaccine development has led to de-escalation in BCG vaccines. Therefore, the COVID-19 pandemic has hampered the market value of the BCG Vaccine market in 2020.
BCG Vaccine Market Segment Analysis
Based on the product, the BCG vaccine market has been classified into Immune BCG and Therapy BCG
Immune BCG segment is projected to be the dominated segment in the market during the forecast period.
Immune BCG dominated the global market in 2019. Also, the Immune BCG is expected to present considerable growth in the near future. BCG Vaccine is administered to new borns in the risk zone areas with a single dose of Immune BCG to prevent TB development. Therefore, the increasing usage of Immune BCG in the prevention of the development of TB is expected to propel segmental growth in the near future.
BCG Vaccine is segmented on the basis of Demographics, which includes Pediatrics (0-18 Years), Adults (19-35 Years).
Pediatrics (0-18 Years) is expected to dominate the BCG Vaccine market.
Pediatrics (0-18 Years) held the dominant position in the global market during the forecast period. In countries where the BCG vaccine is part of the national childhood immunization policy, BCG is normally offered to all children up to one year of age. In addition, older children (over 1 year of age) who have an elevated chance of contracting Tuberculosis should also be given this vaccine. It is rarely administered above 16 years of age and is never administered above 35 years of age, since vaccines are only successful when administered at an early stage of life. This is supporting the segment growth during the forecast period.
Product: DataM Intelligence Analysis (2019)
BCG Vaccine is segmented on the basis of Application, which includes Hospitals, Clinics, Others
Hospitals is expected to dominate the BCG Vaccine market.
Hospitals held the dominant position in the global market during the forecast period. The administration of BCG vaccines done after the birth of baby in the hospitals supports the segment growth during the forecast period. Moreover, the Clinics is expected to project a considerable CAGR during the forecast period. Older children (more than 1 year of age) who have an elevated risk of contracting Tuberculosis may also receive this vaccine administered at Clinics.
BCG Vaccine Market Geographical Analysis
Based on geography, the study analyzes the BCG vaccine market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Asia Pacific is expected to dominate the global BCG Vaccine market
Asia Pacific held a dominant position in the global BCG vaccine market in 2019. In Asia, the India is expected to represent considerable growth during the forecast period. In India, the prevalence of TB was 27% of the total in 2018. Moreover, Middle East and Africa are expected to represent significant growth in value during the forecast period. BCG Vaccine market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the tuberculosis cases in the region coupled with increasing government initiatives to combat the disease.
The BCG vaccine market is highly competitive, owing to the presence of major developments in vaccine production. The key BCG Vaccine players which are contributing to the growth of the global market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotech Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute among others. The major players are adopting new product launch and expansion strategies for global growth in the BCG Vaccine market.
TICE® BCG is an attenuated live culture preparation for intravesical use of the Mycobacterium bovis strain Bacillus of Calmette and Guerin (BCG).1 The TICE strain was developed from a strain originating at the Pasteur Institute at the University of Illinois. At the local site of administration, TICE® BCG causes a granulomatous reaction. Intra-vesical. TICE BCG has been used as a treatment for recurring tumors and prophylaxis against them in Patients of urinary bladder carcinoma in situ (CIS) and to avoid recurrence of Stage III TaT1 papillary bladder tumors are at high risk for recurrence.
Product Portfolio: The Company's portfolio comprises Vaccines, Medications and medical devices among others
Visualize the BCG Vaccine market segmentation composition by product, demographics, application and Region, highlighting the critical commercial assets and players.
Identify commercial opportunities in the BCG Vaccine market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of BCG vaccine market - level 3 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global BCG Vaccine market report would provide access to an approx. 51 market data table, 45 figures and 221 pages.
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
Global Tuberculosis Market
Global Vaccine market
Table of Contents
BCG Vaccine Market Methodology and Scope
Research Methodology
Research Objective and Scope of the Report
BCG Vaccine Market - Market Definition and Overview
BCG Vaccine Market - Executive Summary
Market Snippet by Product
Market Snippet by Demographics
Market Snippet by Application
Market Snippet by Region
BCG Vaccine Market - Market Dynamics
Market Impacting Factors
Drivers
Increasing Prevalence of Tuberculosis in Developing and under-developed countries
Increasing birth rates across the globe
Side effects of BCG vaccine
Impact Analysis
BCG Vaccine Market - Industry Analysis
Porter's Five Forces Analysis
Supply Chain Analysis
Value Chain Analysis
PEST Analysis
Pricing Analysis
Regulatory Analysis
Reimbursement Analysis
Unmet Needs
Patent Trends
BCG Vaccine Market - COVID-19 Analysis
Analysis of Covid-19 on the Market
Before COVID-19 Market Scenario
Present COVID-19 Market Scenario
After COVID-19 or Future Scenario
Pricing Dynamics Amid Covid-19
Demand-Supply Spectrum
Government Initiatives Related to the Market During Pandemic
Manufacturers Strategic Initiatives
Conclusion
BCG Vaccine Market - By Product
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
Market Attractiveness Index, By Product Segment
Immune BCG*
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%)
Therapy BCG
BCG Vaccine Market - By Demographics
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics Segment
Market Attractiveness Index, By Demographics Segment
Pediatrics (0-18 Years)*
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%)
Adults (19-35 Years)
BCG Vaccine Market - By Application
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
Market Attractiveness Index, By Application Segment
Hospitals*
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%)
Clinics
BCG Vaccine Market - By Region
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
Market Attractiveness Index, By Region
North America
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
U.S.
Canada
Mexico
Europe
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
Germany
U.K.
France
Italy
Spain
Rest of Europe
South America
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
Brazil
Argentina
Rest of South America
Asia Pacific
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
China
India
Japan
Australia
Rest of Asia Pacific
Middle East and Africa
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
BCG Vaccine Market - Competitive Landscape
Competitive Scenario
Market Positioning/Share Analysis
Mergers and Acquisitions Analysis
BCG Vaccine Market- Company Profiles
Merck & Co.*
Company Overview
Product Portfolio and Description
Key Highlights
Financial Overview
Sanofi Pasteur
Japan BCG Laboratory
China National Biotech Group
Serum Institute of India Pvt. Ltd
InterVax Ltd
GREENSIGNAL BIO PHARMA LIMITED (GSBPL)
STATENS SERUM INSTITUTE
Other companies (List Not Exhaustive)
BCG Vaccine Market - Premium Insights
BCG Vaccine Market - DataM Intelligence Analysis
Appendix
About Us and Services
Contact Us